Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

January 1, 1996; Volume 156,Issue 1

CUTTING EDGE

  • You have accessRestricted access
    Matrix metalloproteinases in immunity.
    E J Goetzl, M J Banda and D Leppert
    J Immunol January 1, 1996, 156 (1) 1-4;
  • You have accessRestricted access
    Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).
    I A Ferber, S Brocke, C Taylor-Edwards, W Ridgway, C Dinisco, L Steinman, D Dalton and C G Fathman
    J Immunol January 1, 1996, 156 (1) 5-7;
  • You have accessRestricted access
    Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice.
    R D Stout, J Suttles, J Xu, I S Grewal and R A Flavell
    J Immunol January 1, 1996, 156 (1) 8-11;

ARTICLES

  • You have accessRestricted access
    Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
    I Cascino, G Papoff, R De Maria, R Testi and G Ruberti
    J Immunol January 1, 1996, 156 (1) 13-17;
  • You have accessRestricted access
    Induction of microvariant-specific CTL lines reactive to a single amino acid mismatch in bulk cultures using a transfectant expressing a single HLA class I molecule.
    N Cereb and S Y Yang
    J Immunol January 1, 1996, 156 (1) 18-26;
  • You have accessRestricted access
    IL-3 augments TCR-mediated responses of type 2 CD4 T cells.
    Y Dan, Y Katakura, A Ametani, S Kaminogawa and Y Asano
    J Immunol January 1, 1996, 156 (1) 27-34;
  • You have accessRestricted access
    Activated alpha beta-CD8+, but not alpha alpha-CD8+, TCR-alpha beta+ murine intestinal intraepithelial lymphocytes can mediate perforin-based cytotoxicity, whereas both subsets are active in Fas-based cytotoxicity.
    V Gelfanov, V Gelfanova, Y G Lai and N S Liao
    J Immunol January 1, 1996, 156 (1) 35-41;
  • You have accessRestricted access
    Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites.
    M Hansson, A Asea, U Ersson, S Hermodsson and K Hellstrand
    J Immunol January 1, 1996, 156 (1) 42-47;
  • You have accessRestricted access
    In vivo response of mature T cells to Mlsa antigens. Long-term progeny of dividing cells include cells with a naive phenotype.
    K A Hayden, D F Tough and S R Webb
    J Immunol January 1, 1996, 156 (1) 48-55;
  • You have accessRestricted access
    Regulation of NF-kappa B activation in T helper 1 and T helper 2 cells.
    J A Lederer, J S Liou, S Kim, N Rice and A H Lichtman
    J Immunol January 1, 1996, 156 (1) 56-63;
  • You have accessRestricted access
    Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.
    Y M Li, S Arkins, R H McCusker Jr, S M Donovan, Q Liu, S Jayaraman, R Dantzer and K W Kelley
    J Immunol January 1, 1996, 156 (1) 64-72;
  • You have accessRestricted access
    TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice.
    H Maeda and A Shiraishi
    J Immunol January 1, 1996, 156 (1) 73-78;
  • You have accessRestricted access
    Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
    S Miyashima, N Nagata, T Nakagawa, N Hosaka, K Takeuchi, R Ogawa and S Ikehara
    J Immunol January 1, 1996, 156 (1) 79-84;
  • You have accessRestricted access
    Release of a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase from cytotoxic T cells upon activation.
    E Nemoto, S Stohlman and G Dennert
    J Immunol January 1, 1996, 156 (1) 85-92;
  • You have accessRestricted access
    Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms.
    M Schedlowski, W Hosch, R Oberbeck, R J Benschop, R Jacobs, H R Raab and R E Schmidt
    J Immunol January 1, 1996, 156 (1) 93-99;
  • You have accessRestricted access
    CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase.
    O Silvennoinen, H Nishigaki, A Kitanaka, M Kumagai, C Ito, F Malavasi, Q Lin, M E Conley and D Campana
    J Immunol January 1, 1996, 156 (1) 100-107;
  • You have accessRestricted access
    Modulation of rat B cell differentiation in vivo by the administration of an anti-mu monoclonal antibody.
    M Soares, X Havaux, F Nisol, H Bazin and D Latinne
    J Immunol January 1, 1996, 156 (1) 108-118;
  • You have accessRestricted access
    CD40 ligand is expressed and functional on activated neonatal T cells.
    J B Splawski, J Nishioka, Y Nishioka and P E Lipsky
    J Immunol January 1, 1996, 156 (1) 119-127;
  • You have accessRestricted access
    Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. Its unique carbohydrate binding specificity for Tn antigen.
    N Suzuki, K Yamamoto, S Toyoshima, T Osawa and T Irimura
    J Immunol January 1, 1996, 156 (1) 128-135;
  • You have accessRestricted access
    Insertional mutagenesis affecting programmed cell death leads to thymic hyperplasia and altered thymopoiesis.
    A Volkmann, R Döffinger, U Rüther and B A Kyewski
    J Immunol January 1, 1996, 156 (1) 136-145;
  • You have accessRestricted access
    The role of NK cells during in vivo antigen-specific antibody responses.
    J A Wilder, C Y Koh and D Yuan
    J Immunol January 1, 1996, 156 (1) 146-152;
  • You have accessRestricted access
    Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    N S Williams and V H Engelhard
    J Immunol January 1, 1996, 156 (1) 153-159;
  • You have accessRestricted access
    Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane.
    M Xia, D Leppert, S L Hauser, S P Sreedharan, P J Nelson, A M Krensky and E J Goetzl
    J Immunol January 1, 1996, 156 (1) 160-167;
  • You have accessRestricted access
    Promoter region of the human gene coding for beta-chain of C4b binding protein. Hepatocyte nuclear factor-3 and nuclear factor-I/CTF transcription factors are required for efficient expression of C4BPB in HepG2 cells.
    N Arenzana and S Rodríguez de Córdoba
    J Immunol January 1, 1996, 156 (1) 168-175;
  • You have accessRestricted access
    Amino acid residues on the I-Ak alpha-chain required for the binding and stability of two antigenic peptides.
    C A Nelson, N Viner, S Young, S Petzold, C Benoist, D Mathis and E R Unanue
    J Immunol January 1, 1996, 156 (1) 176-182;
  • You have accessRestricted access
    B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching.
    C M Snapper, P Zelazowski, F R Rosas, M R Kehry, M Tian, D Baltimore and W C Sha
    J Immunol January 1, 1996, 156 (1) 183-191;
  • You have accessRestricted access
    Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
    C L Tucek-Szabo, S Andjelić, E Lacy, K B Elkon and J Nikolić-Zugić
    J Immunol January 1, 1996, 156 (1) 192-200;
  • You have accessRestricted access
    Susceptibility to TNF in the presence of inhibitors of transcription or translation is dependent on the activity of cytosolic phospholipase A2 in human melanoma tumor cells.
    C Voelkel-Johnson, T E Thorne and S M Laster
    J Immunol January 1, 1996, 156 (1) 201-207;
  • You have accessRestricted access
    Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.
    A Anichini, R Mortarini, C Maccalli, P Squarcina, K Fleischhauer, L Mascheroni and G Parmiani
    J Immunol January 1, 1996, 156 (1) 208-217;
  • You have accessRestricted access
    Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-alpha production by mast cells.
    E Y Bissonnette, J A Enciso and A D Befus
    J Immunol January 1, 1996, 156 (1) 218-223;
  • You have accessRestricted access
    Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen.
    P W Chen, M Wang, V Bronte, Y Zhai, S A Rosenberg and N P Restifo
    J Immunol January 1, 1996, 156 (1) 224-231;
  • You have accessRestricted access
    In vivo cytokine production in murine listeriosis. Evidence for immunoregulation by gamma delta+ T cells.
    B Hsieh, M D Schrenzel, T Mulvania, H D Lepper, L DiMolfetto-Landon and D A Ferrick
    J Immunol January 1, 1996, 156 (1) 232-237;
  • You have accessRestricted access
    Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.
    K R Irvine, J B Rao, S A Rosenberg and N P Restifo
    J Immunol January 1, 1996, 156 (1) 238-245;
  • You have accessRestricted access
    Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    B M Mitchell and J G Stevens
    J Immunol January 1, 1996, 156 (1) 246-255;
  • You have accessRestricted access
    Ceramide inhibits IgE-mediated activation of phospholipase D, but not of phospholipase C, in rat basophilic leukemia (RBL-2H3) cells.
    Y Nakamura, S Nakashima, K Ojio, Y Banno, H Miyata and Y Nozawa
    J Immunol January 1, 1996, 156 (1) 256-262;
  • You have accessRestricted access
    IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
    J F Urban Jr, R Fayer, S J Chen, W C Gause, M K Gately and F D Finkelman
    J Immunol January 1, 1996, 156 (1) 263-268;
  • You have accessRestricted access
    Involvement of bradykinin B1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1 beta in vivo in the mouse.
    A Ahluwalia and M Perretti
    J Immunol January 1, 1996, 156 (1) 269-274;
  • You have accessRestricted access
    Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression.
    J A Cairns and A F Walls
    J Immunol January 1, 1996, 156 (1) 275-283;
  • You have accessRestricted access
    A common epitope on platelet integrin alpha IIb beta 3 (glycoprotein IIbIIIa; CD41b/CD61) and alpha M beta 2 (Mac-1; CDIIb/CD18) detected by a monoclonal antibody.
    M O De Nichilo, D R Shafren, W M Carter, M C Berndt, G F Burns and A W Boyd
    J Immunol January 1, 1996, 156 (1) 284-288;
  • You have accessRestricted access
    Analysis of bovine gamma delta T cell interactions with E-, P-, and L-selectin. Characterization of lymphocyte on lymphocyte rolling and the effects of O-glycoprotease.
    M A Jutila and S Kurk
    J Immunol January 1, 1996, 156 (1) 289-296;
  • You have accessRestricted access
    Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization.
    A L Kindzelskii, Z O Laska, R F Todd 3rd and H R Petty
    J Immunol January 1, 1996, 156 (1) 297-309;
  • You have accessRestricted access
    Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro.
    S Laberge, W W Cruikshank, D J Beer and D M Center
    J Immunol January 1, 1996, 156 (1) 310-315;
  • You have accessRestricted access
    Cholera toxin increases IL-6 synthesis and decreases TNF-alpha production by rat peritoneal mast cells.
    I Leal-Berumen, D P Snider, C Barajas-Lopez and J S Marshall
    J Immunol January 1, 1996, 156 (1) 316-321;
  • You have accessRestricted access
    Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release.
    P Loetscher, M Seitz, I Clark-Lewis, M Baggiolini and B Moser
    J Immunol January 1, 1996, 156 (1) 322-327;
  • You have accessRestricted access
    Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity.
    J A McLachlan, C D Serkin and O Bakouche
    J Immunol January 1, 1996, 156 (1) 328-335;
  • You have accessRestricted access
    Metabolism and biologic effects of 5-oxoeicosanoids on human neutrophils.
    W S Powell, R J MacLeod, S Gravel, F Gravelle and A Bhakar
    J Immunol January 1, 1996, 156 (1) 336-342;
  • You have accessRestricted access
    Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts.
    C D Richards, C Langdon, F Botelho, T J Brown and A Agro
    J Immunol January 1, 1996, 156 (1) 343-349;
  • You have accessRestricted access
    Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide.
    B Zingarelli, M O'Connor, H Wong, A L Salzman and C Szabó
    J Immunol January 1, 1996, 156 (1) 350-358;
  • You have accessRestricted access
    Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression.
    Y Collette, H L Chang, C Cerdan, H Chambost, M Algarte, C Mawas, J Imbert, A Burny and D Olive
    J Immunol January 1, 1996, 156 (1) 360-370;
  • You have accessRestricted access
    Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein.
    J M Greer, R A Sobel, A Sette, S Southwood, M B Lees and V K Kuchroo
    J Immunol January 1, 1996, 156 (1) 371-379;
  • You have accessRestricted access
    Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
    H Li, C L Kaufman, S S Boggs, P C Johnson, K D Patrene and S T Ildstad
    J Immunol January 1, 1996, 156 (1) 380-388;
  • You have accessRestricted access
    IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer.
    A C Ogilvie, C E Hack, J Wagstaff, G J van Mierlo, A J Erenberg, L L Thomsen, K Hoekman and E M Rankin
    J Immunol January 1, 1996, 156 (1) 389-394;
  • You have accessRestricted access
    Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    B Wasowska, K J Wieder, W W Hancock, X X Zheng, B Berse, J Binder, T B Strom and J W Kupiec-Weglinski
    J Immunol January 1, 1996, 156 (1) 395-404;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 156, Issue 1
1 Jan 1996
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • CUTTING EDGE
  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606